Astrazeneca Fights To Regain Cancer Market Prominence | Latest News RSS feed

Astrazeneca Fights To Regain Cancer Market Prominence - Latest News


AstraZeneca fights to regain cancer market prominence

(Corrects typo in headline to read 'AstraZeneca' and not 'AztraZeneca') By Deena Beasley CHICAGO, June 3 (Reuters) - AstraZeneca Plc, in the headlines for spurning buyout offers from Pfizer Inc, aims ... read more

Global Prostate Cancer Therapeutics Industry

Inc. - AstraZeneca Plc - Bayer AG Read the full report: https://www.reportlinker.com/p03915682 PROSTATE CANCER THERAPEUTICS MCP-1 MARKET ANALYSIS, TRENDS, AND FORECASTS, JANUARY 2 CONTENTS I. ... read more

AstraZeneca's Lynparza, armed with new FDA nod, aims to regain share from Tesaro's Zejula

Lynparza can now fight back. The AstraZeneca drug—now shared ... in their respective first quarters on the market launch, Moulder said. RELATED: AZ looks to extend PARP lead with solid Lynparza breast ... read more

Looking for another news?


AstraZeneca, Merck strike deal to advance cancer treatments

The Merck tie-up illustrates the growing prominence ... AstraZeneca's Lynparza (olaparib) for multiple cancer types", the pair said. Lynparza is currently approved for treatment of ovarian cancer but ... read more


Drugs giants strike deal to advance cancer treatments (Update)

British pharmaceutical giant AstraZeneca and US peer Merck said Thursday they had agreed a multi-billion-dollar deal to jointly develop ... for treatment of ovarian cancer but it is hoped that this ... read more

3 Promising Cancer Immunotherapies to Watch in 2018

Immunotherapies work by spurring the body's immune system to fight cancer ... in clinical-stage development or on the market. Out of that vast number, I think there are three especially promising ... read more

Novartis hires Harvard star to plug gaps in cancer drug arsenal

James “Jay” Bradner, from Harvard’s Dana-Farber Cancer ... to fight tumors that evade the body’s natural defenses. Merck’s Keytruda is on the market, as is Bristol-Myers’ Opdivo, while Roche aims for ... read more

AstraZeneca, Merck strike key cancer drugs partnership

The Merck tie-up illustrates the growing prominence ... AstraZeneca's Lynparza (olaparib) for multiple cancer types", the pair said. Lynparza is currently approved for treatment of ovarian cancer but ... read more

3 Promising Cancer Immunotherapies to Watch in 2018

Immunotherapies work by spurring the body's immune system to fight cancer. The approach has gained such incredible traction in the research community that there are now over 2,000 immunotherapies in ... read more

AstraZeneca fights to regain cancer market prominence

(Corrects typo in headline to read 'AstraZeneca (NYSE: AZN - news) ' and not 'AztraZeneca') By Deena Beasley CHICAGO, June 3 (Reuters) - AstraZeneca Plc, in the headlines for spurning buyout offers ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us